Elsevier

The Lancet

Volume 344, Issue 8933, 12 November 1994, Pages 1347-1349
The Lancet

Placebo in medicine
Placebo effect in double-blind clinical trials: a review of interactions with medications

https://doi.org/10.1016/S0140-6736(94)90699-8Get rights and content

First page preview

First page preview
Click to open first page preview

References (18)

There are more references available in the full text version of this article.

Cited by (178)

  • A qualitative exploration of how patients conceptualise their acupuncturists: Technicians, caring professionals, and wise healers

    2016, Complementary Therapies in Medicine
    Citation Excerpt :

    We have previously described in detail our epistemology (critical realist) and analytic approach.39 In brief, we began by using techniques from framework analysis42 to organise patients’ talk into five domains of contextual features: themselves in relation to acupuncture, acupuncture consultations and treatments, their acupuncturist, their relationship with their acupuncturist, and the physical and institutional setting of acupuncture.14,43 The findings reported below emerged from an inductive thematic analysis44,45 of patients’ talk about their acupuncturist.

  • Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence

    2015, Journal of Clinical Epidemiology
    Citation Excerpt :

    It uses a subtractive rationale: By comparing a true treatment group to a sham group, it factually subtracts the effect of the true treatment from those of the control treatment and only looks at the difference, neglecting everything else [10,38]. This procedure makes a vital assumption that has rarely been tested and if tested has been found to be wrong [39]: Namely that the treatment components are additive and that the nonspecific effects are roughly stable and uncorrelated with treatment effects across trials. The latter assumption has been shown to be wrong: Treatment and placebo effects are highly correlated at r = 0.78 in a variety of studies with treatment duration of more than 3 months [40].

  • Placebo Studies (Double-Blind Studies)

    2015, International Encyclopedia of the Social & Behavioral Sciences: Second Edition
  • Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study

    2014, Pain
    Citation Excerpt :

    Physiologically this could occur if there is an overlap in some component of the pain reduction pathways for the mind– body effect and the specific effect of the active medication. In this subadditive state [1,13,26,27], the overall group response and ratio of placebo to active medication group responses can change based on the degree of overlap (Fig. 4b). If there is also a maximal total benefit possible from the active medication treatment, the differences between groups would be as diagrammed in Fig. 4c.

View all citing articles on Scopus
View full text